Chen V - Search Results

1

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.

Kim C, Liu SV, Crawford J, Torres T, Chen V, Thompson J, Tan M, Esposito G, Subramaniam DS, Giaccone G. Kim C, et al. Among authors: chen v. Front Oncol. 2021 Sep 8;11:728155. doi: 10.3389/fonc.2021.728155. eCollection 2021. Front Oncol. 2021. PMID: 34568058 Free PMC article.

2

Serum CRIPTO does not confer drug resistance against osimertinib but is an indicator of tumor burden in non-small cell lung cancer.

Chen V, Iwama E, Kim IK, Giaccone G. Chen V, et al. Lung Cancer. 2020 Jul;145:48-57. doi: 10.1016/j.lungcan.2020.04.032. Epub 2020 May 5. Lung Cancer. 2020. PMID: 32408132 Free article.

3

Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation.

Zhao X, Kim IK, Kallakury B, Chahine JJ, Iwama E, Pierobon M, Petricoin E, McCutcheon JN, Zhang YW, Umemura S, Chen V, Wang C, Giaccone G. Zhao X, et al. Among authors: chen v. Mol Oncol. 2021 Apr;15(4):1130-1145. doi: 10.1002/1878-0261.12882. Epub 2021 Jan 26. Mol Oncol. 2021. PMID: 33320980 Free PMC article.

4

Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.

Umemura S, Chen V, Chahine JJ, Kallakury B, Zhao X, Lee H, Avantaggiati ML, He Y, Wang C, Giaccone G. Umemura S, et al. Among authors: chen v. Clin Lung Cancer. 2022 Mar;23(2):e140-e147. doi: 10.1016/j.cllc.2021.07.006. Epub 2021 Jul 20. Clin Lung Cancer. 2022. PMID: 34393062

5

Downregulation of CYLD promotes IFN-γ mediated PD-L1 expression in thymic epithelial tumors.

Umemura S, Zhu J, Chahine JJ, Kallakury B, Chen V, Kim IK, Zhang YW, Goto K, He Y, Giaccone G. Umemura S, et al. Among authors: chen v. Lung Cancer. 2020 Sep;147:221-228. doi: 10.1016/j.lungcan.2020.07.018. Epub 2020 Jul 22. Lung Cancer. 2020. PMID: 32738418

6

Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.

Chen V, Umemura S, Han Y, Raman R, Tucker R, Chahine J, Kim IK, Schatz C, Zitzmann-Kolbe S, Sommer A, Onda M, Lee T, He Y, Giaccone G. Chen V, et al. Br J Cancer. 2022 Mar;126(5):754-763. doi: 10.1038/s41416-021-01658-6. Epub 2021 Dec 7. Br J Cancer. 2022. PMID: 34876673 Free PMC article.

7

A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.

He Y, Kim IK, Bian J, Polyzos A, Di Giammartino DC, Zhang YW, Luo J, Hernandez MO, Kedei N, Cam M, Borczuk AC, Lee T, Han Y, Conner EA, Wong M, Tillo DC, Umemura S, Chen V, Ruan L, White JB, Miranda IC, Awasthi PP, Altorki NK, Divakar P, Elemento O, Apostolou E, Giaccone G. He Y, et al. Among authors: chen v. J Thorac Oncol. 2022 Dec;17(12):1375-1386. doi: 10.1016/j.jtho.2022.08.008. Epub 2022 Aug 30. J Thorac Oncol. 2022. PMID: 36049655 Free PMC article.

8

The roads to ferroptosis under homeostatic versus pathological conditions.

Chen V, Bo C, Gu W. Chen V, et al. Mol Cell Oncol. 2021 Oct 6;8(5):1970477. doi: 10.1080/23723556.2021.1970477. eCollection 2021. Mol Cell Oncol. 2021. PMID: 34859139 Free PMC article.

9

PLAC1 as a serum biomarker for breast cancer.

Yuan H, Chen V, Boisvert M, Isaacs C, Glazer RI. Yuan H, et al. Among authors: chen v. PLoS One. 2018 Feb 12;13(2):e0192106. doi: 10.1371/journal.pone.0192106. eCollection 2018. PLoS One. 2018. PMID: 29432428 Free PMC article.

10

Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening.

Chen VHE, Ong L, Teo WK, Siow CH, Goh HL, Tan C, Lim WS, Eu D, Cheong ISY, Chan SH, Loh KS, Tay JK. Chen VHE, et al. Head Neck. 2024 May 30. doi: 10.1002/hed.27790. Online ahead of print. Head Neck. 2024. PMID: 38817018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,425 results

Search Page